An action letter is anticipated before the end of 2014. Carbella is the proposed US trade name for intravenous carbamazepine. Oral carbamazepine is an important treatment option for
The trial met its primary efficacy endpoint of a statistically significant improvement in kidney function. Specifically, a dose of 1.5mg/m2 led to a statistically significant (p=0.045) increase in
Marco Ruo of Marchesini noted worth €1m, the packaging line will demonstrate the hardware and software that is required by pharmaceutical customers to comply with industry regulations for
The guidance does not include patients with highly active MS. The guidance published by the SMC represents an important step in improving the standard of care available to
Genentech is currently marketing Xeloda in the US. Teva claims that it was the first to receive approval on its abbreviated new drug application from the US Food
Curcumin is an active product that is generated from the spice, turmeric. It has been consumed for centuries in other parts of the world without posing any side
The FDA’s Fast Track process is designed to facilitate the development and expedite the review of drugs to treat serious conditions that fill an unmet medical need, with
The patent includes claims to the use of the company’s drug candidate, Trimesta (oral estriol), in conjunction with a gestagen for the treatment of multiple sclerosis (MS) and
The DSMB’s review of the efficacy data is still pending. Northwest Biotherapeutics chief technical officer Dr. Marnix Bosch noted the company is pleased with the recommendation of the
The trial met its primary efficacy endpoint by showing a significantly lower ‘Total Combined Rhinitis Score’ (TCRS) when compared with patients who received placebo. The trial also showed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.